Anil Kumar Vyas

Anil Kumar Vyas

Active Director Director DIN 02417592
DIN 02417592 First appointment Feb 2009 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Total affiliations 5 Since Feb 2009
Shareholding value •••• Premium profile

About Anil Kumar Vyas

Data last updated:

Anil Kumar Vyas is a Director at Mednext Biotech Limited (since 2017), Director at Alice Pharma Private Limited (since 2010) and Director at Ceza Formulations Private Limited (since 2014), and holds 2 more current directorships. The companies operate in Pharma and Financial Services. The 5 current companies with reported revenue have a combined latest revenue of ₹67.68 Cr; the largest is Mednext Biotech Limited at ₹36.86 Cr (FY 2025).

DIN 02417592
Primary Designation Director
Industry Pharma
First Appointment 03 Feb 2009
Oldest Company Age 27 yrs
Largest company Mednext Biotech Limited · ₹36.86 Cr (FY 2025)
Combined revenue ₹67.68 Cr across 5 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mednext Biotech Limited U24232RJ2012PLC039813
Director10 Oct 20172012₹36.86 Cr (FY 2025)Active
Alice Pharma Private Limited U24232MP2006PTC019099
Director25 Nov 20102006₹21.91 Cr (FY 2025)Active
Ceza Formulations Private Limited U24232MP1999PTC013421
Director13 Dec 20141999₹3.60 Cr (FY 2024)Active
Tirtham Hospitality Private Limited U55101RJ2021PTC076956
Director13 Sep 20212021₹2.75 Cr (FY 2024)Active
Mednext Pharma Private Limited U24110MH2009PTC190076
Director03 Feb 20092009₹2.56 Cr (FY 2024)Active

Directorship timeline

Open interactive timeline →
Mednext Pharma Private Limited
Ceza Formulations Private Limited
Alice Pharma Private Limited
Mednext Biotech Limited
Premium access

Shareholding and investment profile for Anil Kumar Vyas

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anil Kumar Vyas

Anil Kumar Vyas currently holds 5 directorships: Mednext Biotech Limited (Director, since 10 Oct 2017, revenue ₹36.86 Cr (FY 2025)); Alice Pharma Private Limited (Director, since 25 Nov 2010, revenue ₹21.91 Cr (FY 2025)); Ceza Formulations Private Limited (Director, since 13 Dec 2014, revenue ₹3.60 Cr (FY 2024)); Tirtham Hospitality Private Limited (Director, since 13 Sep 2021, revenue ₹2.75 Cr (FY 2024)); Mednext Pharma Private Limited (Director, since 03 Feb 2009, revenue ₹2.56 Cr (FY 2024)).

Anil Kumar Vyas was first appointed on 03 Feb 2009 as Director at Mednext Pharma Private Limited. The most recent appointment on record is 13 Sep 2021 at Tirtham Hospitality Private Limited.

The 5 current companies of Anil Kumar Vyas that report revenue have a combined latest revenue of ₹67.68 Cr: Mednext Biotech Limited ₹36.86 Cr (FY 2025); Alice Pharma Private Limited ₹21.91 Cr (FY 2025); Ceza Formulations Private Limited ₹3.60 Cr (FY 2024); Tirtham Hospitality Private Limited ₹2.75 Cr (FY 2024); Mednext Pharma Private Limited ₹2.56 Cr (FY 2024).

The current boards of Anil Kumar Vyas's companies include Neelam Vyas (Mednext Biotech Limited), Shriansh Vyas (Mednext Biotech Limited), Alex Charles Fernandes (Alice Pharma Private Limited), Leena Alex Fernandes (Alice Pharma Private Limited), Krishnakant Mundra (Ceza Formulations Private Limited), Mimoh Paliwal (Ceza Formulations Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available